Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference1 articles.
1. A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting;Jones;Cancer Treat. Rev.,1982
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial;Journal of Clinical Oncology;2024-08-16
2. The use of cannabinoids in palliating cancer-related symptoms: a narrative review;Baylor University Medical Center Proceedings;2024-01-12
3. Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours;Frontiers in Immunology;2023-02-22
4. Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer;Supportive Care in Cancer;2022-12-16
5. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications;BMC Medicine;2022-08-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3